Skip to main content
Equibles

Swedbank AB

Bank

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 946431 STOCKHOLM, V7
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$18,631,950
-$1,953,126 QoQ
Shares Held
61,894
-0.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swedbank AB holds $1,349,039,135 across 23 Biotechnology names. ALNY ranks #8 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 10,726,608 $601,440,910
2 JAZZ
Jazz Pharmaceuticals plc
 968,092 $233,281,129
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 282,444 $140,298,407
4 REGN
Regeneron Pharmaceuticals, Inc.
 189,848 $118,377,821
5 BMRN
Biomarin Pharmaceutical Inc
 1,314,787 $75,232,112
6 EXEL
Exelixis, Inc.
 841,778 $45,801,140
7 INCY
Incyte Corp
 371,387 $42,100,430
8 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		61,894 $18,631,950

All Filings in ALNY

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,631,950 61,894
2026-03-31 $20,585,076 62,215
2025-12-31 $24,631,236 61,942
2025-09-30 $28,991,568 63,578
2025-06-30 $20,972,478 64,315
2025-03-31 $16,199,309 59,993
2024-12-31 $13,067,234 55,532
2024-09-30 $14,777,086 53,729
2024-06-30 $5,015,277 20,639
2024-03-31 $3,084,498 20,639
2023-12-31 $42,232,510 220,639
2023-09-30 $39,075,166 220,639
2023-06-30 $63,428,943 333,942
2023-03-31 $66,895,261 333,942
2022-12-31 $101,394,085 426,653
2022-09-30 $83,278,569 416,060
2022-06-30 $64,059,070 439,212
2022-03-31 $71,579,151 438,356
2021-12-31 $74,032,692 436,565
2021-09-30 $82,415,187 436,498
2021-06-30 $58,571,194 345,512
2021-03-31 $48,049,639 340,319